Published in
Dove Press, Pharmacogenomics and Personalized Medicine, (Volume 10), p. 217-227
DOI: 10.2147/pgpm.s136341
Links
Tools
CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications
Journal article published in 2017 by
Jennifer St. Sauver 
,
Janet Olson,
Veronique Roger,
Wayne Nicholson,
John Logan Black,
Paul Takahashi,
Pedro Caraballo ,
Elizabeth J. Bell,
Debra Jacobson,
Nicholas Larson ,
Suzette Bielinski
,
Janet Olson,
Veronique Roger,
Wayne Nicholson,
John Logan Black,
Paul Takahashi,
Pedro Caraballo ,
Elizabeth J. Bell,
Debra Jacobson,
Nicholas Larson ,
Suzette Bielinski
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 